CAS 1564242-30-3

3-Azetidineacetonitrile, 1-(ethyl-2,2,2-d3-sulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-

Formel: C₁₆H₁₇N₇O₂S

InChl: InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)/i1D3

InChI Key: XUZMWHLSFXCVMG-FIBGUPNXSA-N

SMILES: [2H]C([2H])([2H])CS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3

Synonyme:

• 3-Azetidineacetonitrile, 1-(ethyl-2,2,2-d3-sulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-
• Baricitinib-d3

Baricitinib-D3

CAS: 1564242-30-3

Baricitinib-D3 is the deuterated form of Baricitinib. Baricitinib (T2485) (LY3009104; INCB028050) acts as a selective and orally administered inhibitor of JAK1 and JAK2, with IC₅₀ values of 5.9 nM and 5.7 nM, respectively.

Formel: C₁₆H₁₇N₇O₂S

Farbe und Form: Solid

Molekulargewicht: 374.44

Ref: TM-TMID-1196